VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,072,104 | -60.7% | 861,484 | +2.9% | 0.00% | -50.0% |
Q2 2023 | $20,531,412 | +7.2% | 836,992 | +1.7% | 0.00% | 0.0% |
Q1 2023 | $19,155,119 | -9.5% | 823,168 | -1.6% | 0.00% | -20.0% |
Q4 2022 | $21,169,283 | +50.4% | 836,400 | +14.6% | 0.01% | +66.7% |
Q3 2022 | $14,077,000 | -21.3% | 730,087 | +4.0% | 0.00% | -25.0% |
Q2 2022 | $17,880,000 | +153.3% | 701,993 | +155.7% | 0.00% | +300.0% |
Q1 2022 | $7,060,000 | -39.5% | 274,503 | -1.6% | 0.00% | -50.0% |
Q4 2021 | $11,677,000 | +2.5% | 278,884 | +6.5% | 0.00% | 0.0% |
Q3 2021 | $11,392,000 | +0.4% | 261,752 | +9.1% | 0.00% | 0.0% |
Q2 2021 | $11,342,000 | +29.2% | 239,891 | +40.0% | 0.00% | 0.0% |
Q1 2021 | $8,782,000 | +80.9% | 171,306 | -5.5% | 0.00% | +100.0% |
Q4 2020 | $4,854,000 | -14.3% | 181,225 | +9.8% | 0.00% | 0.0% |
Q3 2020 | $5,664,000 | +11.6% | 165,006 | +33.3% | 0.00% | 0.0% |
Q2 2020 | $5,073,000 | +654.9% | 123,830 | +531.2% | 0.00% | – |
Q1 2020 | $672,000 | +312.3% | 19,617 | +51.6% | 0.00% | – |
Q4 2019 | $163,000 | – | 12,943 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |